Sermorelin 15mg — Vial Spec, Reconstitution Math & COA
A 15mg vial of Sermorelin represents a high-capacity lyophilized cake of growth hormone-releasing hormone (GHRH 1-29) fragment formulated for extended, high-throughput preclinical research assays and multi-plate in vitro studies. Principal investigators select this larger unit size to maintain batch consistency across protracted experimental timelines while reducing per-milligram handling variability. While PX1 Research catalog inventory primary listings focus on standardized laboratory formats accessible via our main [Sermorelin product page](/product/sermorelin), mastering 15mg concentration calculations and analytical validation protocols remains essential for quantitative laboratory design.
Quick answer
A 15mg vial of Sermorelin represents a high-capacity lyophilized cake of growth hormone-releasing hormone (GHRH 1-29) fragment formulated for extended, high-throughput preclinical research assays and multi-plate in vitro studies. Principal investigators select this larger unit size to maintain batch consistency across protracted experimental timelines while reducing per-milligram handling variability. While PX1 Research catalog inventory primary listings focus on standardized laboratory formats accessible via our main [Sermorelin product page](/product/sermorelin), mastering 15mg concentration calculations and analytical validation protocols remains essential for quantitative laboratory design.
Key takeaways
- A 15mg [Sermorelin](/research-peptides/sermorelin) research vial contains 15 milligrams of purified, vacuum-sealed lyophilized peptide acetate salt.
- [Sermorelin](/research-peptides/sermorelin) represents the shortest fully functional synthetic fragment of naturally occurring GHRH.
- Accurate concentration calculations are mandatory when reconstituting a 15mg lyophilized peptide cake.
- Reconstituting a single 15mg vial creates a substantial working liquid volume.
Sermorelin 15mg Mass Specification and Product Availability
A 15mg Sermorelin research vial contains 15 milligrams of purified, vacuum-sealed lyophilized peptide acetate salt. Sermorelin acetate is a synthetic 29-amino-acid peptide corresponding to the amino-terminal segment of endogenous Human Growth Hormone-Releasing Hormone (GHRH 1-29 amide). In laboratory settings, this specific 15mg mass allocation is classified as a bulk or extended-run research unit. It is predominantly utilized by institutional facilities running automated liquid handlers, cell culture assays, or continuous animal models requiring consistent peptide exposure across multiple laboratory arrays without switching reagent lot numbers.
It is critical for research staff to note current catalog availability: PX1 Research supplies high-purity GHRH analogs in standardized 2mg, 5mg, and 10mg single-vial formats. If your experimental design specifically requires a 15mg format or custom mass fills, PX1 Research provides custom synthesis and bulk lot fulfillment. To view currently stocked catalog sizes, researchers can navigate our complete all peptides catalog or consult directly with our technical support team for custom batch requirements.
Chemical Structure and Preclinical Mechanism of Action
Sermorelin represents the shortest fully functional synthetic fragment of naturally occurring GHRH. Comprising amino acids 1 through 29 of the full-length 44-amino-acid hypothalamic peptide, Sermorelin retains complete receptor-binding affinity for the growth hormone-releasing hormone receptor (GHRH-R), a G-protein-coupled receptor located on pituitary somatotroph cells. Preclinical studies suggest that upon binding to GHRH-R, Sermorelin activates the adenylate cyclase pathway, stimulating intracellular cyclic adenosine monophosphate (cAMP) production and downstream protein kinase A (PKA) signaling.
In vitro data indicate that this signaling cascade promotes both the gene expression and pulsatile exocytosis of endogenous growth hormone (GH). Because Sermorelin contains only the bioactive 29-amino-acid domain, it offers an ideal molecular model for studying receptor-ligand kinetics, negative feedback sensitivity via somatostatin release, and somatotroph responsiveness without the structural complexity of full-length GHRH(1-44).
Reconstitution Mathematics for 15mg Lyophilized Vials
Accurate concentration calculations are mandatory when reconstituting a 15mg lyophilized peptide cake. Because 15mg represents 15,000 micrograms (mcg) of active mass, reconstituting with standard laboratory diluent volumes yields significantly higher concentrations per microliter than smaller 2mg or 5mg vials. Researchers must carefully plan fluid volumes to ensure volumetric measurement precision on precision pipettes.
When adding 1.0 mL of sterile bacteriostatic water or target assay diluent to a 15mg vial, the resulting final concentration is 15.0 mg/mL (15.0 mcg/µL). When adding 2.0 mL of diluent, the concentration yields 7.5 mg/mL (7.5 mcg/µL). Reconstitution with 3.0 mL of diluent achieves a working concentration of 5.0 mg/mL (5.0 mcg/µL). For high-precision assay pipetting where micro-liter adjustments are required, adding 5.0 mL of diluent creates a standard 3.0 mg/mL (3.0 mcg/µL) stock solution. To perform custom volumetric calculations tailored to specific multi-well concentration ranges, researchers should utilize our automated reconstitution calculator.
Aliquot Planning and Degradation Prevention
Reconstituting a single 15mg vial creates a substantial working liquid volume. Repeated entry into a single reconstituted vial increases the risk of atmospheric exposure, bacterial contamination, and enzymatic or thermal degradation. Once the lyophilized cake is fully dissolved in bacteriostatic water or buffered saline, the working solution must be rapidly portioned into single-use or single-assay micro-aliquots using sterile, low-binding polypropylene microcentrifuge tubes.
Exposing a reconstituted peptide solution to repeated freeze-thaw cycles causes physical shear stress and ice crystal formation that disrupt peptide chain integrity, leading to aggregation and activity loss. For optimal stability, sub-aliquots intended for short-term use (within 7 to 14 days) should be held at 2°C to 8°C. Sub-aliquots intended for long-term experimental timelines (up to 3–6 months) must be immediately flash-frozen and stored at -20°C or -80°C. Never re-freeze an aliquot once thawed for benchwork.
Lot-Matched COA Verification & Analytical Standards
Every peptide lot produced for PX1 Research undergoes stringent third-party testing in an ISO 17025 accredited analytical laboratory. Quality control for a 15mg fill specification requires rigorous verification to confirm mass uniformity, chemical purity, and the absence of biological contaminants. Researchers can instantly download lot-specific analytical documentation through our dedicated certificate of analysis page.
Analytical verification of Sermorelin relies on two primary orthogonal methods: High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). HPLC analysis confirms chemical purity by measuring the relative area under the curve (AUC), ensuring a target purity threshold of ≥98.0%. Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) or Liquid Chromatography-Mass Spectrometry (LC-MS) verifies the exact molecular weight (3,357.9 Da) to confirm sequence identity. Furthermore, every batch undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure bacterial endotoxin levels remain strictly below <0.01 EU/mg, protecting sensitive cell lines and animal models from inflammatory interference.
Comparative Analysis: Sermorelin vs. CJC-1295, Ipamorelin, and GHRP-2
When designing GHRH and growth factor receptor assays, investigators frequently compare Sermorelin against other synthetic secretagogues to evaluate binding dynamics and half-life differences. For instance, CJC-1295 No DAC is a 30-amino-acid modified GHRH analog designed with four substituted amino acids that enhance plasma stability compared to native Sermorelin. While Sermorelin exhibits a short half-life in vitro (approx. 10–12 minutes) due to rapid cleavage by dipeptidyl peptidase IV (DPP-IV), CJC-1295 resists enzymatic degradation, offering an extended signaling window.
In contrast to GHRH analogs, ghrelin receptor agonists target the Growth Hormone Secretagogue Receptor (GHS-R1a) rather than the GHRH receptor. Compounds such as Ipamorelin and GHRP-2 act synergistically with Sermorelin. In preclinical models, co-administration of a GHRH-R ligand (Sermorelin) alongside a GHS-R1a ligand (Ipamorelin or GHRP-2) demonstrates a dual-receptor amplification effect, inducing a significantly greater pulse of somatotroph GH release than either agent administered in isolation.
Storage Protocols: Temperature Controls for Dry Cake and Liquid Reconstitution
Maintaining ambient temperature control is critical to preventing hydrolysis and oxidation of the lyophilized Sermorelin cake. Unreconstituted 15mg vials stored at controlled room temperature (20°C to 25°C) remain stable for short shipping durations. However, upon arrival at the laboratory facility, sealed desiccated vials should be immediately placed in cold storage at -20°C for routine short-term storage or -80°C for multi-year stability.
Lyophilized cakes are highly hygroscopic. Before reconstituting, the vial must be allowed to acclimate to room temperature inside a laminar flow hood to prevent atmospheric moisture condensation inside the vial upon rubber stopper puncture. Reconstitution should be performed gently: inject diluent along the glass wall of the vial and swirl smoothly. Avoid vigorous vortexing or shaking, which can introduce air bubbles, surface denaturation, and mechanical aggregate formation.
Evaluating Vial Sizes: 2mg, 5mg, 10mg vs. 15mg for High-Throughput Screening
Selecting the appropriate vial mass depends entirely on experimental scale, fluid throughput, and assay frequency. A 15mg vial offers distinct logistical benefits for automated liquid handlers executing high-throughput screening (HTS) across dozens of 96-well or 384-well plates, where preparing multiple smaller vials introduces concentration variance and step-wise error. Institutional researchers managing high-volume studies can inquire about bulk volume pricing and custom manufacturing runs via our wholesale peptide portal.
Conversely, for lower-frequency benchtop experiments or exploratory pilot studies, smaller vial formats (such as 2mg or 5mg) are generally preferred. Reconstituting a 15mg vial for occasional single-well assays risks wasting material if liquid aliquots degrade over extended storage weeks. Matching the physical vial mass to the weekly consumption rate of your protocol ensures optimal chemical integrity and minimizes reagent degradation.
PX1 Research Quality Commitments and Domestic Fulfillment
PX1 Research operates as a premier domestic vendor dedicated exclusively to the scientific research community. All research peptides are manufactured in GMP-compliant facilities adhering to strict United States quality standards. Every batch undergoes comprehensive identity, purity, and safety validation prior to distribution, ensuring consistent performance from assay to assay.
To support rigorous laboratory schedules, PX1 Research maintains centralized distribution hubs in California and Arizona, providing same-day dispatch for orders placed Monday through Friday before 12:00 PM PST. Vials are packaged with temperature-protective insulation and secure tamper-evident seals to safeguard product integrity during transit. Explore our comprehensive peptide research hub to access chemical documentation, analytical frameworks, and technical guidance for laboratory investigation.
Frequently Asked Questions
What is the concentration of a Sermorelin 15mg vial reconstituted with 3mL of diluent?
Reconstituting a 15mg vial with 3.0 mL of diluent yields a final concentration of 5.0 mg/mL, which corresponds to 5.0 micrograms (mcg) per microliter (µL).
Does PX1 Research currently stock standard 15mg Sermorelin catalog vials?
PX1 Research stocks standard catalog sizes such as 2mg, 5mg, and 10mg vials for immediate fulfillment. The 15mg mass specification is supplied as a custom synthesis or bulk order fill for qualified research institutions.
What is the primary receptor target of Sermorelin in preclinical assays?
Sermorelin selectively binds to and activates the Growth Hormone-Releasing Hormone Receptor (GHRH-R) located on pituitary somatotroph cells, stimulating adenylate cyclase and cAMP signaling pathways.
How should reconstituted liquid aliquots of Sermorelin 15mg be stored?
Reconstituted liquid aliquots should be portioned into single-use polypropylene tubes. Short-term working aliquots (1–14 days) should be stored at 2°C to 8°C, while long-term storage requires freezing at -20°C or -80°C.
What endotoxin limits are verified for PX1 Research peptides?
All PX1 Research lots undergo chromogenic LAL endotoxin testing to ensure levels remain under <0.01 EU/mg, preventing cell culture toxicity or non-specific inflammatory signaling.
Why is freeze-thaw cycling damaging to reconstituted Sermorelin?
Repeated freeze-thaw cycles subject the solubilized peptide to physical shear stress and localized concentration spikes during ice formation, leading to irreversible peptide chain denaturation and aggregation.
How does Sermorelin differ structurally from full-length GHRH?
Sermorelin consists of the 29-amino-acid N-terminal sequence (GHRH 1-29 amide) of natural human GHRH, containing the complete biological activity required for GHRH-R binding and activation.
Where are PX1 Research peptide products manufactured and shipped from?
PX1 Research peptides are manufactured in USA-based GMP-compliant facilities and shipped directly from dual distribution hubs located in California and Arizona with same-day M-F dispatch.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.